XML 23 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Total Shareholders' Equity
Total Shareholders' Equity
Cumulative Effect, Period of Adoption, Adjustment
Preferred Stock
Common Stock
Additional Paid-In Capital
AOCI
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
NCI
Beginning balance (in shares) at Dec. 31, 2019         0 140,000,000          
Beginning balance at Dec. 31, 2019 $ 1,584   $ 1,488   $ 0 $ 1 $ 166 $ (380) $ 1,701   $ 96
Beginning balance (ASC 842) at Dec. 31, 2019   $ (2)   $ (2)           $ (2)  
Increase (Decrease) in Shareholders' Equity                      
Net earnings (loss) (367)   (435)           (435)   68
OCI (36)   (37)         (37)     1
Dividends (14)   (14)           (14)    
Capital contributions (distributions) by NCI, net 87                   87
Other NCI transactions (9)   10       10       (19)
Stock-based plan activity (in shares)           1,000,000          
Stock-based plan activity 20   20       20        
Ending balance (in shares) at Dec. 31, 2020         0 141,000,000          
Ending balance at Dec. 31, 2020 1,263   1,030   $ 0 $ 1 196 (417) 1,250   233
Increase (Decrease) in Shareholders' Equity                      
Net earnings (loss) (401)   (440)           (440)   39
OCI 52   51         51     1
Issuance of CPS (in shares)         1,000,000            
Issuance of CPS $ 582   582       582        
Preferred Stock, Dividends Per Share, Declared $ 16.25                    
Dividends, Preferred Stock $ 19   19           19    
Capital contributions (distributions) by NCI, net 93                   93
Other NCI transactions (31)   161       161       (192)
Stock-based plan activity 28   28       28        
Ending balance (in shares) at Dec. 31, 2021         1,000,000 141,000,000          
Ending balance at Dec. 31, 2021 1,567   1,393   $ 0 $ 1 967 (366) 791   174
Increase (Decrease) in Shareholders' Equity                      
Net earnings (loss) 73   145           145   (72)
OCI $ 2   1         1     1
Preferred Stock, Dividends Per Share, Declared $ 16.25                    
Dividends, Preferred Stock $ 39   39           39    
Capital contributions (distributions) by NCI, net (39)                   (39)
NuScale reverse recapitalization 292   147       147       145
Sale of NuScale units to NCI 107   107       107        
Other NCI transactions 21   20       20       1
Stock-based plan activity (in shares)           1,000,000          
Stock-based plan activity 12   12     $ 0 13   (1)    
Ending balance (in shares) at Dec. 31, 2022         1,000,000 142,000,000          
Ending balance at Dec. 31, 2022 $ 1,996   $ 1,786   $ 0 $ 1 $ 1,254 $ (365) $ 896   $ 210